{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:41:28Z","timestamp":1792734088069,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40257-026-01044-z","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:51:16Z","timestamp":1780465876000},"page":"697-707","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Practical Therapeutic Strategies for Acne-Induced Hyperpigmentation Across all Skin Types"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8816-1989","authenticated-orcid":false,"given":"Jose L.","family":"Lopez-Estebaranz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4385-5935","authenticated-orcid":false,"given":"Marta","family":"Lopez-Pando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2893-3609","authenticated-orcid":false,"given":"Keila","family":"Mitsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"7","key":"1044_CR1","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/1346-8138.13263","volume":"43","author":"F Abad-Casintahan","year":"2016","unstructured":"Abad-Casintahan F, Chow SKW, Goh CL, Kubba R, Hayashi N, Noppakun N, et al. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation. J Dermatol. 2016;43(7):826\u20138. https:\/\/doi.org\/10.1111\/1346-8138.13263.","journal-title":"J Dermatol"},{"issue":"6","key":"1044_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40257-021-00633-4","volume":"22","author":"N Elbuluk","year":"2021","unstructured":"Elbuluk N, Grimes P, Chien A, Hamzavi I, Alexis A, Taylor S, et al. The pathogenesis and management of acne-induced post-inflammatory hyperpigmentation. Am J Clin Dermatol. 2021;22(6):829\u201336. https:\/\/doi.org\/10.1007\/s40257-021-00633-4.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"1044_CR3","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/09546634.2018.1542807","volume":"30","author":"A Abanmi","year":"2019","unstructured":"Abanmi A, Al-Enezi M, Al Hammadi A, Galadari I, Kibbi AG, Zimmo S. Survey of acne-related post-inflammatory hyperpigmentation in the Middle East. J Dermatolog Treat. 2019;30(6):578\u201381. https:\/\/doi.org\/10.1080\/09546634.2018.1542807.","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"1044_CR4","first-page":"20","volume":"3","author":"EC Davis","year":"2010","unstructured":"Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3(7):20\u201331.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"5","key":"1044_CR5","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1080\/09546634.2021.1981814","volume":"33","author":"MG Tan","year":"2022","unstructured":"Tan MG, Kim WB, Jo CE, Nabieva K, Kirshen C, Ortiz AE. Topical treatment for postinflammatory hyperpigmentation: a systematic review. J Dermatolog Treat. 2022;33(5):2518\u201326. https:\/\/doi.org\/10.1080\/09546634.2021.1981814.","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"1044_CR6","first-page":"387","volume":"80","author":"AF Alexis","year":"2007","unstructured":"Alexis AF, Sergay AB, Taylor SC. Common dermatologic disorders in skin of color: a comparative practice survey. Cutis. 2007;80(5):387\u201394.","journal-title":"Cutis"},{"key":"1044_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jdin.2021.06.006","volume":"5","author":"A Layton","year":"2021","unstructured":"Layton A, Alexis A, Baldwin H, Beissert S, Bettoli V, Del Rosso J, et al. Identifying gaps and providing recommendations to address shortcomings in the investigation of acne sequelae by the Personalising Acne: Consensus of Experts Panel. JAAD Int. 2021;5:41\u20138. https:\/\/doi.org\/10.1016\/j.jdin.2021.06.006.","journal-title":"JAAD Int"},{"issue":"4","key":"1044_CR8","first-page":"24","volume":"3","author":"EC Davis","year":"2010","unstructured":"Davis EC, Callender VD. A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies. J Clin Aesthet Dermatol. 2010;3(4):24\u201338.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"6","key":"1044_CR9","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/ijd.17189","volume":"63","author":"A Alexis","year":"2024","unstructured":"Alexis A, Del Rosso JQ, Forman S, Martorell A, Browning J, Laquer V, et al. Importance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induced post-inflammatory hyperpigmentation. Int J Dermatol. 2024;63(6):806\u201315. https:\/\/doi.org\/10.1111\/ijd.17189.","journal-title":"Int J Dermatol"},{"issue":"2","key":"1044_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/JCAS.JCAS_171_18","volume":"12","author":"S Arsiwala","year":"2019","unstructured":"Arsiwala S, Desai S. Fractional carbon dioxide laser: optimizing treatment outcomes for pigmented atrophic acne scars in skin of color. J Cutan Aesthet Surg. 2019;12(2):85\u201394. https:\/\/doi.org\/10.4103\/JCAS.JCAS_171_18.","journal-title":"J Cutan Aesthet Surg"},{"issue":"4","key":"1044_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jaad.2017.01.035","volume":"77","author":"N Silpa-Archa","year":"2017","unstructured":"Silpa-Archa N, Kohli I, Chaowattanapanit S, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. J Am Acad Dermatol. 2017;77(4):591\u2013605. https:\/\/doi.org\/10.1016\/j.jaad.2017.01.035.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"1044_CR12","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1111\/jdv.17242","volume":"35","author":"T Passeron","year":"2021","unstructured":"Passeron T, Lim HW, Goh CL, Kang HY, Ly F, Morita A, et al. Photoprotection according to skin phototype and dermatoses: practical recommendations from an expert panel. J Eur Acad Dermatol Venereol. 2021;35(7):1460\u20139. https:\/\/doi.org\/10.1111\/jdv.17242.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1044_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/exd.13854","volume":"28","author":"EM Burns","year":"2019","unstructured":"Burns EM, Ahmed H, Isedeh PN, Kohli I, Van Der Pol W, Shaheen A, et al. Ultraviolet radiation, both UVA and UVB, influences the composition of the skin microbiome. Exp Dermatol. 2019;28(2):136\u201341. https:\/\/doi.org\/10.1111\/exd.13854.","journal-title":"Exp Dermatol"},{"issue":"Suppl. 1","key":"1044_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-4632.2007.03463.x","volume":"46","author":"F Poli","year":"2007","unstructured":"Poli F. Acne on pigmented skin. Int J Dermatol. 2007;46(Suppl. 1):39\u201341. https:\/\/doi.org\/10.1111\/j.1365-4632.2007.03463.x.","journal-title":"Int J Dermatol"},{"issue":"2","key":"1044_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/0974-2077.184043","volume":"9","author":"CL Goh","year":"2016","unstructured":"Goh CL, Noppakun N, Micali G, Azizan NZ, Boonchai W, Chan Y, et al. Meeting the challenges of acne treatment in Asian patients: a review of the role of dermocosmetics as adjunctive therapy. J Cutan Aesthet Surg. 2016;9(2):85\u201392. https:\/\/doi.org\/10.4103\/0974-2077.184043.","journal-title":"J Cutan Aesthet Surg"},{"key":"1044_CR16","unstructured":"Features C. A review of the epidemiology, clinical features, and treatment options in skin of color. Year study population prevalence rank. 2010;3(7)."},{"issue":"3","key":"1044_CR17","doi-asserted-by":"publisher","DOI":"10.4081\/dr.2021.8223","volume":"13","author":"F Al-Qarqaz","year":"2021","unstructured":"Al-Qarqaz F, Bodoor K, Baba A, Al-Yousef A, Muhaidat J, Alshiyab D. Post-acne hyperpigmentation: evaluation of risk factors and the use of artificial neural network as a predictive classifier. Dermatol Rep. 2021;13(3):8223. https:\/\/doi.org\/10.4081\/dr.2021.8223.","journal-title":"Dermatol Rep"},{"issue":"5","key":"1044_CR18","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/bjd\/ljad026","volume":"188","author":"B Schuster","year":"2023","unstructured":"Schuster B, Gallinger J, Philipp-Dormston WG, Vasel M, Layton AM. Less confident, successful and happy: patients with post-acne hyperpigmentation are stigmatized. Br J Dermatol. 2023;188(5):682\u20134. https:\/\/doi.org\/10.1093\/bjd\/ljad026.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1044_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jaad.2013.09.017","volume":"70","author":"SA Savory","year":"2014","unstructured":"Savory SA, Agim NG, Mao R, Peter S, Wang C, Maldonado G, et al. Reliability assessment and validation of the postacne hyperpigmentation index (PAHPI), a new instrument to measure postinflammatory hyperpigmentation from acne vulgaris. J Am Acad Dermatol. 2014;70(1):108\u201314. https:\/\/doi.org\/10.1016\/j.jaad.2013.09.017.","journal-title":"J Am Acad Dermatol"},{"key":"1044_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2340\/actadv.v105.42925","volume":"105","author":"N Auffret","year":"2025","unstructured":"Auffret N, Leccia MT, Ballanger F, Claudel JP, Dahan S, Dr\u00e9no B. Acne-induced post-inflammatory hyperpigmentation: from grading to treatment. Acta Derm Venereol. 2025;105:1\u20139. https:\/\/doi.org\/10.2340\/actadv.v105.42925.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"1044_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.70055","volume":"24","author":"CE Kesty","year":"2025","unstructured":"Kesty CE, Kesty KR. The Kesty Hyperpigmentation Scale: a study to validate a new tool for assessing facial hyperpigmentation. J Cosmet Dermatol. 2025;24(4):e70055. https:\/\/doi.org\/10.1111\/jocd.70055.","journal-title":"J Cosmet Dermatol"},{"key":"1044_CR22","doi-asserted-by":"crossref","unstructured":"Dabbas D. Comparison of MELASQOL and DLQI in female patients suffering from melasma and nonmelasma facial melanosis: a cross-sectional study. Pigment Int. 2023;10(2):93\u201396.","DOI":"10.4103\/pigmentinternational.pigmentinternational_3_22"},{"issue":"3","key":"1044_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136. https:\/\/doi.org\/10.1111\/j.1365-2230.1994.tb01167.x.","journal-title":"Clin Exp Dermatol"},{"issue":"11","key":"1044_CR24","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/archderm.1997.03890470111018","volume":"133","author":"MM Chren","year":"1997","unstructured":"Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133(11):1433\u201340.","journal-title":"Arch Dermatol"},{"issue":"Suppl. 1","key":"1044_CR25","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/s0923-1811(01)00116-5","volume":"27","author":"K Yoshimura","year":"2001","unstructured":"Yoshimura K, Tsukamoto K, Okazaki M, Virador VM, Lei TC, Suzuki Y, et al. Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of melanocytes. J Dermatol Sci. 2001;27(Suppl. 1):S68-75. https:\/\/doi.org\/10.1016\/s0923-1811(01)00116-5.","journal-title":"J Dermatol Sci"},{"issue":"4 Pt 2","key":"1044_CR26","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/s0190-9622(86)70236-3","volume":"15","author":"PM Elias","year":"1986","unstructured":"Elias PM. Epidermal effects of retinoids: supramolecular observations and clinical implications. J Am Acad Dermatol. 1986;15(4 Pt 2):797\u2013809. https:\/\/doi.org\/10.1016\/s0190-9622(86)70236-3.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1044_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2165\/00128071-200910040-00005","volume":"10","author":"HY Kang","year":"2009","unstructured":"Kang HY, Valerio L, Bahadoran P, Ortonne JP. The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review. Am J Clin Dermatol. 2009;10(4):251\u201360. https:\/\/doi.org\/10.2165\/00128071-200910040-00005.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"1044_CR28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/bjd.16719","volume":"179","author":"J Aubert","year":"2018","unstructured":"Aubert J, Piwnica D, Bertino B, Blanchet-R\u00e9thor\u00e9 S, Carlavan I, D\u00e9ret S, et al. Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-\u03b3 agonist trifarotene. Br J Dermatol. 2018;179(2):442\u201356. https:\/\/doi.org\/10.1111\/bjd.16719.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1044_CR29","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s13555-025-01344-y","volume":"15","author":"N Issa","year":"2025","unstructured":"Issa N, Alexis A, Baldwin H, Hamzavi I, Hebert A, Kwong P, et al. Recommendations to improve outcomes in acne and acne sequelae: a focus on trifarotene and other retinoids. Dermatol Ther. 2025;15(3):563\u201377. https:\/\/doi.org\/10.1007\/s13555-025-01344-y.","journal-title":"Dermatol Ther"},{"issue":"20","key":"1044_CR30","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJM199305203282002","volume":"328","author":"SM Bulengo-Ransby","year":"1993","unstructured":"Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, Finkel LJ, Hamilton TA, Ellis CN, et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in Black patients. N Engl J Med. 1993;328(20):1438\u201343. https:\/\/doi.org\/10.1056\/NEJM199305203282002.","journal-title":"N Engl J Med"},{"issue":"4 Suppl.","key":"1044_CR31","first-page":"48","volume":"68","author":"WK Jacyk","year":"2001","unstructured":"Jacyk WK, Mpofu P. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients. Cutis. 2001;68(4 Suppl.):48\u201354.","journal-title":"Cutis"},{"issue":"1","key":"1044_CR32","first-page":"45","volume":"77","author":"P Grimes","year":"2006","unstructured":"Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Cutis. 2006;77(1):45\u201350.","journal-title":"Cutis"},{"issue":"20","key":"1044_CR33","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1001\/jama.2021.17633","volume":"326","author":"DZ Eichenfield","year":"2021","unstructured":"Eichenfield DZ, Sprague J, Eichenfield LF. Management of acne vulgaris: a review. JAMA. 2021;326(20):2055\u201367. https:\/\/doi.org\/10.1001\/jama.2021.17633.","journal-title":"JAMA"},{"issue":"6","key":"1044_CR34","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jaad.2019.02.044","volume":"80","author":"J Tan","year":"2019","unstructured":"Tan J, Thiboutot D, Popp G, Gooderham M, Lynde C, Del Rosso J, et al. Randomized phase 3 evaluation of trifarotene 50 \u03bcg\/g cream treatment of moderate facial and truncal acne. J Am Acad Dermatol. 2019;80(6):1691\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2019.02.044.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1044_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1365-2133.1994.tb13101.x","volume":"130","author":"L Hegemann","year":"1994","unstructured":"Hegemann L, Toso SM, Kitay K, Webster GF. Anti-inflammatory actions of benzoyl peroxide: effects on the generation of reactive oxygen species by leucocytes and the activity of protein kinase C and calmodulin. Br J Dermatol. 1994;130(5):569\u201375. https:\/\/doi.org\/10.1111\/j.1365-2133.1994.tb13101.x.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1044_CR36","first-page":"417","volume":"82","author":"JJ Leyden","year":"2008","unstructured":"Leyden JJ, Wortzman M, Baldwin EK. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%. Cutis. 2008;82(6):417\u201321.","journal-title":"Cutis"},{"issue":"4","key":"1044_CR37","doi-asserted-by":"publisher","first-page":"306","DOI":"10.18231\/j.ijced.2019.064","volume":"5","author":"S Kumar","year":"2019","unstructured":"Kumar S, Devi B, Goud V. A comparative study of Acne vulgaris with special reference to therapeutic options. IP Indian J Clin Exp Dermatol. 2019;5(4):306\u201311. https:\/\/doi.org\/10.18231\/j.ijced.2019.064.","journal-title":"IP Indian J Clin Exp Dermatol"},{"issue":"5","key":"1044_CR38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3109\/09546634.2012.699179","volume":"24","author":"NH Mohd Nor","year":"2013","unstructured":"Mohd Nor NH, Aziz Z. A systematic review of benzoyl peroxide for Acne vulgaris. J Dermatolog Treat. 2013;24(5):377\u201386. https:\/\/doi.org\/10.3109\/09546634.2012.699179.","journal-title":"J Dermatolog Treat"},{"issue":"10","key":"1044_CR39","first-page":"1107","volume":"17","author":"L Amar","year":"2018","unstructured":"Amar L, Kircik LH. Treatment of moderate acne vulgaris in Fitzpatrick skin type V or VI: efficacy and tolerability of fixed combination clindamycin phosphate 1.2%\/benzoyl peroxide 3.75% gel. J Drugs Dermatol. 2018;17(10):1107\u201312.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"1044_CR40","first-page":"586","volume":"10","author":"LH Kircik","year":"2011","unstructured":"Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol. 2011;10(6):586\u201390.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"1044_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/0974-2077.110089","volume":"6","author":"R Sarkar","year":"2013","unstructured":"Sarkar R, Arora P, Garg KV. Cosmeceuticals for hyperpigmentation: what is available? J Cutan Aesthet Surg. 2013;6(1):4\u201311. https:\/\/doi.org\/10.4103\/0974-2077.110089.","journal-title":"J Cutan Aesthet Surg"},{"issue":"12","key":"1044_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28124839","volume":"28","author":"AM Thawabteh","year":"2023","unstructured":"Thawabteh AM, Jibreen A, Karaman D, Thawabteh A, Karaman R. Skin pigmentation types, causes and treatment: a review. Molecules. 2023;28(12):4839. https:\/\/doi.org\/10.3390\/molecules28124839.","journal-title":"Molecules"},{"issue":"1","key":"1044_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1046\/j.1365-2133.2002.04834.x","volume":"147","author":"T Hakozaki","year":"2002","unstructured":"Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147(1):20\u201331. https:\/\/doi.org\/10.1046\/j.1365-2133.2002.04834.x.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1044_CR44","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40257-017-0333-6","volume":"19","author":"BP Kaufman","year":"2018","unstructured":"Kaufman BP, Aman T, Alexis AF. Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis and treatment. Am J Clin Dermatol. 2018;19(4):489\u2013503. https:\/\/doi.org\/10.1007\/s40257-017-0333-6.","journal-title":"Am J Clin Dermatol"},{"issue":"9","key":"1044_CR45","doi-asserted-by":"publisher","first-page":"769","DOI":"10.36849\/JDD.8309","volume":"23","author":"JK Hu","year":"2024","unstructured":"Hu JK, Quinonez RL, Antasiuk V, Waibel J. Treatment of acne vulgaris-associated post-inflammatory dyschromia with combination of non-ablative laser therapy and topical antioxidants. J Drugs Dermatol. 2024;23(9):769\u201373. https:\/\/doi.org\/10.36849\/JDD.8309.","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"1044_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/jid.1952.16","volume":"18","author":"CR Denton","year":"1952","unstructured":"Denton CR, Lerner AB, Fitzpatrick TB. Inhibition of melanin formation by chemical agents. J Invest Dermatol. 1952;18(2):119\u201335. https:\/\/doi.org\/10.1038\/jid.1952.16.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"1044_CR47","first-page":"1","volume":"9","author":"RM Halder","year":"2004","unstructured":"Halder RM, Richards GM. Topical agents used in the management of hyperpigmentation. Skin Therapy Lett. 2004;9(6):1\u20133.","journal-title":"Skin Therapy Lett"},{"issue":"6","key":"1044_CR48","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1365-2133.1975.tb05110.x","volume":"93","author":"GH Findlay","year":"1975","unstructured":"Findlay GH, Morrison JG, Simson IW. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams. Br J Dermatol. 1975;93(6):613\u201322. https:\/\/doi.org\/10.1111\/j.1365-2133.1975.tb05110.x.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1044_CR49","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4103\/0019-5154.169122","volume":"60","author":"PA Bhattar","year":"2015","unstructured":"Bhattar PA, Zawar VP, Godse KV, Patil SP, Nadkarni NJ, Gautam MM. Exogenous ochronosis. Indian J Dermatol. 2015;60(6):537\u201343. https:\/\/doi.org\/10.4103\/0019-5154.169122.","journal-title":"Indian J Dermatol"},{"issue":"1","key":"1044_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jrms.jrms_443_22","volume":"28","author":"M Sobhan","year":"2023","unstructured":"Sobhan M, Talebi-Ghane E, Poostiyan E. A comparative study of 20% azelaic acid cream versus 5% tranexamic acid solution for the treatment of postinflammatory hyperpigmentation in patients with acne vulgaris: a single-blinded randomized clinical trial. J Res Med Sci. 2023;28(1):1\u20137. https:\/\/doi.org\/10.4103\/jrms.jrms_443_22.","journal-title":"J Res Med Sci"},{"issue":"3","key":"1044_CR51","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jaad.2010.06.040","volume":"65","author":"CJ Hodgkiss-Harlow","year":"2011","unstructured":"Hodgkiss-Harlow CJ, Eichenfield LF, Dohil MA. Effective monitoring of isotretinoin safety in a pediatric dermatology population: a novel \u201cpatient symptom survey\u201d approach. J Am Acad Dermatol. 2011;65(3):517\u201324. https:\/\/doi.org\/10.1016\/j.jaad.2010.06.040.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1044_CR52","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/bjd.21739","volume":"187","author":"I Mavranezouli","year":"2022","unstructured":"Mavranezouli I, Daly CH, Welton NJ, Deshpande S, Berg L, Bromham N, et al. A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris. Br J Dermatol. 2022;187(5):639\u201349. https:\/\/doi.org\/10.1111\/bjd.21739.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1044_CR53","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/09546639609089553","volume":"7","author":"JJ Leyden","year":"1996","unstructured":"Leyden JJ, Kaidbey K, Gans E. The antimicrobial effects in vivo of minocycline, doxycycline and tetracycline in humans. J Dermatol Treat. 1996;7(4):223\u20135. https:\/\/doi.org\/10.3109\/09546639609089553.","journal-title":"J Dermatol Treat"},{"issue":"6","key":"1044_CR54","first-page":"281","volume":"4","author":"M Bjellerup","year":"1987","unstructured":"Bjellerup M, Ljunggren B. Double blind cross-over studies on phototoxicity to three tetracycline derivatives in human volunteers. Photodermatol. 1987;4(6):281\u20137.","journal-title":"Photodermatol"},{"issue":"4","key":"1044_CR55","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/jocd.15561","volume":"22","author":"TT Mahjoub","year":"2023","unstructured":"Mahjoub TT, Milibary HH. Oral tranexamic acid in the treatment of hyperpigmentation disorder beyond melasma: a review. J Cosmet Dermatol. 2023;22(4):1157\u201362. https:\/\/doi.org\/10.1111\/jocd.15561.","journal-title":"J Cosmet Dermatol"},{"issue":"40","key":"1044_CR56","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3126\/kumj.v10i4.10993","volume":"10","author":"D Karn","year":"2012","unstructured":"Karn D, Kc S, Amatya A, Razouria EA, Timalsina M. Oral tranexamic acid for the treatment of melasma. Kathmandu Univ Med J. 2012;10(40):40\u20133. https:\/\/doi.org\/10.3126\/kumj.v10i4.10993.","journal-title":"Kathmandu Univ Med J"},{"issue":"5","key":"1044_CR57","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/ced.12835","volume":"41","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Park JY, Shibata T, Fujiwara R, Kang HY. Efficacy and possible mechanisms of topical tranexamic acid in melasma. Clin Exp Dermatol. 2016;41(5):480\u20135. https:\/\/doi.org\/10.1111\/ced.12835.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"1044_CR58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0923-1811(92)90050-l","volume":"4","author":"A Takashima","year":"1992","unstructured":"Takashima A, Yasuda S, Mizuno N. Determination of the action spectrum for UV-induced plasminogen activator synthesis in mouse keratinocytes in vitro. J Dermatol Sci. 1992;4(1):11\u20137. https:\/\/doi.org\/10.1016\/0923-1811(92)90050-l.","journal-title":"J Dermatol Sci"},{"issue":"2","key":"1044_CR59","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12016-016-8540-0","volume":"51","author":"Z Hofman","year":"2016","unstructured":"Hofman Z, de Maat S, Hack CE, Maas C. Bradykinin: inflammatory product of the coagulation system. Clin Rev Allergy Immunol. 2016;51(2):152\u201361. https:\/\/doi.org\/10.1007\/s12016-016-8540-0.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"1044_CR60","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jdermsci.2007.01.009","volume":"46","author":"EH Kim","year":"2007","unstructured":"Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007;46(2):111\u20136. https:\/\/doi.org\/10.1016\/j.jdermsci.2007.01.009.","journal-title":"J Dermatol Sci"},{"issue":"2","key":"1044_CR61","doi-asserted-by":"publisher","first-page":"368","DOI":"10.20471\/acc.2023.62.02.16","volume":"62","author":"K Ga\u0107ina","year":"2023","unstructured":"Ga\u0107ina K, Krstanovi\u0107 \u0106osi\u0107 A. The use of tranexamic acid in dermatology. Acta Clin Croat. 2023;62(2):368\u201372. https:\/\/doi.org\/10.20471\/acc.2023.62.02.16.","journal-title":"Acta Clin Croat"},{"issue":"2","key":"1044_CR62","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jaad.2016.03.001","volume":"75","author":"HC Lee","year":"2016","unstructured":"Lee HC, Thng TGS, Goh CL. Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. J Am Acad Dermatol. 2016;75(2):385\u201392. https:\/\/doi.org\/10.1016\/j.jaad.2016.03.001.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1044_CR63","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1473-2165.2011.00583.x","volume":"10","author":"J Sharad","year":"2011","unstructured":"Sharad J. Combination of microneedling and glycolic acid peels for the treatment of acne scars in dark skin. J Cosmet Dermatol. 2011;10(4):317\u201323. https:\/\/doi.org\/10.1111\/j.1473-2165.2011.00583.x.","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"1044_CR64","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1177\/12034754241265716","volume":"28","author":"K Mar","year":"2024","unstructured":"Mar K, Khalid B, Maazi M, Ahmed R, Wang OJ, Khosravi-Hafshejani T. Treatment of post-inflammatory hyperpigmentation in skin of colour: a systematic review. J Cutan Med Surg. 2024;28(5):473\u201380. https:\/\/doi.org\/10.1177\/12034754241265716.","journal-title":"J Cutan Med Surg"},{"issue":"11","key":"1044_CR65","first-page":"41","volume":"14","author":"Chandrashekar","year":"2021","unstructured":"Chandrashekar, Vadlamudi L, Shenoy C. Safety of performing superficial chemical peels in patients on oral isotretinoin for acne and acne-induced pigmentation. J Clin Aesthet Dermatol. 2021;14(11):41\u20133.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"3","key":"1044_CR66","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4103\/JCAS.JCAS_135_18","volume":"12","author":"R Sarkar","year":"2019","unstructured":"Sarkar R, Ghunawat S, Garg VK. Comparative study of 35% glycolic acid, 20% salicylic-10% mandelic acid, and phytic acid combination peels in the treatment of active acne and postacne pigmentation. J Cutan Aesthet Surg. 2019;12(3):158\u201363. https:\/\/doi.org\/10.4103\/JCAS.JCAS_135_18.","journal-title":"J Cutan Aesthet Surg"},{"issue":"11","key":"1044_CR67","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1111\/jocd.14502","volume":"20","author":"G Casabona","year":"2021","unstructured":"Casabona G, Alfertshofer MG, Kaye KO, Frank K, Mercado-Perez A, Hargiss JB, et al. Safety and efficacy of microneedling technology in the treatment of acne scars. J Cosmet Dermatol. 2021;20(11):3482\u201391. https:\/\/doi.org\/10.1111\/jocd.14502.","journal-title":"J Cosmet Dermatol"},{"issue":"7","key":"1044_CR68","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/1346-8138.13263","volume":"43","author":"F Abad\u2010Casintahan","year":"2016","unstructured":"Abad\u2010Casintahan F, Chow SKW, Goh CL, Kubba R, Hayashi N, Noppakun N, et al. Frequency and characteristics of acne\u2010related post\u2010inflammatory hyperpigmentation. J Dermatol. 2016;43(7):826\u20138. https:\/\/doi.org\/10.1111\/1346-8138.13263.","journal-title":"J Dermatol"},{"issue":"2","key":"1044_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jocd.70018","volume":"24","author":"W Feng","year":"2025","unstructured":"Feng W, Yang L. Low-fluence Q-Switch 1064 Nm laser combined with oral tranexamic acid: a quicker treatment for laser-induced postinflammatory hyperpigmentation. J Cosmet Dermatol. 2025;24(2):1\u20138. https:\/\/doi.org\/10.1111\/jocd.70018.","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"1044_CR70","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s13555-022-00719-9","volume":"12","author":"X Wu","year":"2022","unstructured":"Wu X, Wang X, Wu X, Cen Q, Xi W, Shang Y, et al. Intense pulsed light therapy improves acne-induced post-inflammatory erythema and hyperpigmentation: a retrospective study in Chinese patients. Dermatol Ther (Heidelb). 2022;12(5):1147\u201356. https:\/\/doi.org\/10.1007\/s13555-022-00719-9.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"Jan","key":"1044_CR71","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2147\/CCID.S497696","volume":"18","author":"J Yang","year":"2025","unstructured":"Yang J, Shen J, Kong Y, Wang L, Yao Z, Liang J, et al. Successful treatment of facial multiple melanocytic nevus-like dark macules caused by severe acne vulgaris by a single session of intense pulsed light treatment. Clin Cosmet Investig Dermatol. 2025;18(Jan):427\u201330. https:\/\/doi.org\/10.2147\/CCID.S497696.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"5","key":"1044_CR72","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/DSS.0000000000003733","volume":"49","author":"NC Syder","year":"2023","unstructured":"Syder NC, Chen A, Elbuluk N. Radiofrequency and radiofrequency microneedling in skin of color: a review of usage, safety, and efficacy. Dermatol Surg. 2023;49(5):489\u201393. https:\/\/doi.org\/10.1097\/DSS.0000000000003733.","journal-title":"Dermatol Surg"},{"issue":"9","key":"1044_CR73","doi-asserted-by":"publisher","DOI":"10.7759\/cureus","volume":"16","author":"S Jaiswal","year":"2024","unstructured":"Jaiswal S, Jawade S. Microneedling in dermatology: a comprehensive review of applications, techniques, and outcomes. Cureus. 2024;16(9):e70033. https:\/\/doi.org\/10.7759\/cureus.","journal-title":"Cureus"},{"issue":"1","key":"1044_CR74","first-page":"1","volume":"21","author":"B Sofen","year":"2016","unstructured":"Sofen B, Prado G, Emer J. Melasma and post inflammatory hyperpigmentation: management update and expert opinion. Skin Therapy Lett. 2016;21(1):1\u20137.","journal-title":"Skin Therapy Lett"},{"issue":"5","key":"1044_CR75","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/lsm.23152","volume":"52","author":"GR Ahn","year":"2020","unstructured":"Ahn GR, Kim JM, Park SJ, Li K, Kim BJ. Selective sebaceous gland electrothermolysis using a single microneedle radiofrequency device for acne patients: a prospective randomized controlled study. Lasers Surg Med. 2020;52(5):396\u2013401. https:\/\/doi.org\/10.1002\/lsm.23152.","journal-title":"Lasers Surg Med"},{"issue":"1","key":"1044_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-51133-w","volume":"14","author":"HJ Han","year":"2024","unstructured":"Han HJ, Kim JC, Park YJ, Kang HY. Targeting the dermis for melasma maintenance treatment. Sci Rep. 2024;14(1):949. https:\/\/doi.org\/10.1038\/s41598-023-51133-w.","journal-title":"Sci Rep"},{"issue":"1","key":"1044_CR77","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.70001","volume":"41","author":"M de Troya-Mart\u00edn","year":"2025","unstructured":"de Troya-Mart\u00edn M, Rodr\u00edguez-Mart\u00ednez A, Rivas-Ruiz F, Subert A, Arellano-Mendoza MI, Calzavara-Pinton P, et al. Personalized photoprotection: expert consensus and recommendations from a Delphi study among dermatologists. Photodermatol Photoimmunol Photomed. 2025;41(1):e70001. https:\/\/doi.org\/10.1111\/phpp.70001.","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"3","key":"1044_CR78","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/jvc2.408","volume":"3","author":"M Benzaquen","year":"2024","unstructured":"Benzaquen M, Salah S, Nior\u00e9 M, Kerob D. Efficacy of a dermocosmetic skin care regimen in reducing acne-associated post-inflammatory hyperpigmentation in subjects with phototypes IV to VI. JEADV Clin Pract. 2024;3(3):914\u20136. https:\/\/doi.org\/10.1002\/jvc2.408.","journal-title":"JEADV Clin Pract"},{"issue":"7","key":"1044_CR79","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.jid.2018.01.019","volume":"138","author":"T Mann","year":"2018","unstructured":"Mann T, Gerwat W, Batzer J, Eggers K, Scherner C, Wenck H, et al. Inhibition of human tyrosinase requires molecular motifs distinctively different from mushroom tyrosinase. J Invest Dermatol. 2018;138(7):1601\u20138. https:\/\/doi.org\/10.1016\/j.jid.2018.01.019.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"1044_CR80","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/ics.12626","volume":"42","author":"WG Philipp-Dormston","year":"2020","unstructured":"Philipp-Dormston WG, Vila Echag\u00fce A, P\u00e9rez Damonte SH, Riedel J, Filbry A, Warnke K, et al. Thiamidol containing treatment regimens in facial hyperpigmentation: an international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study. Int J Cosmet Sci. 2020;42(4):377\u201387. https:\/\/doi.org\/10.1111\/ics.12626.","journal-title":"Int J Cosmet Sci"},{"issue":"2","key":"1044_CR81","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16735","volume":"24","author":"AL Demessant-Flavigny","year":"2025","unstructured":"Demessant-Flavigny AL, Petkar G, Jodun D, Le Dantec G, Le Floc\u2019h C, Kerob D. Efficacy of a 2-MNG-containing depigmenting serum in the treatment of post-inflammatory hyperpigmentation. J Cosmet Dermatol. 2025;24(2):e70033. https:\/\/doi.org\/10.1111\/jocd.16735.","journal-title":"J Cosmet Dermatol"},{"issue":"9","key":"1044_CR82","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s13555-025-01473-4","volume":"15","author":"T Passeron","year":"2025","unstructured":"Passeron T, Kerob D, Le Dantec G, Demessant-Flavigny AL, do Nascimento AR, Moura R, et al. Efficacy and tolerability of a new facial 2-mercaptonicotinoyl glycine-containing depigmenting serum versus hydroquinone 4% over 3-month treatment of facial melasma. Dermatol Ther (Heidelb). 2025;15(9):2379\u201390. https:\/\/doi.org\/10.1007\/s13555-025-01473-4.","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-026-01044-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-026-01044-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-026-01044-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:35:00Z","timestamp":1792733700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-026-01044-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1044"],"URL":"https:\/\/doi.org\/10.1007\/s40257-026-01044-z","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"21 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No funding was received for the preparation of this article.","order":1,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jose L. Lopez Estebaranz served as a consultant, participated in clinical trials and\/or received speaking fees from\u00a0Almirall, BMS, Janssen, Leo-Pharma, Lilly, AbbVie, Bioderma, Galderma, UCB,\u00a0Novartis, Pierre-Fabre, Invasix, Isdin, and Incyte.Marta L .Pando has no conflicts of interest that are directly relevant to the content of this article. Keila Mitsunaga received support for travel\/meeting participation from Recordati Rare Diseases, Kyowa Kirin, Almirall, Asterasys, Isdin, Cantabria Labs, and Leo Pharma.","order":2,"name":"Ethics","label":"Conflicts of Interest\/Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data are available upon request to the corresponding author.","order":6,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":7,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JLLE was responsible for conceptualization, methodology, data acquisition and analysis, and writing, editing, and revising the manuscript. MLP was responsible for methodology, data acquisition and analysis, and writing, editing, and revising the manuscript. KM was responsible for conceptualization, methodology, data acquisition and analysis, and writing, editing, and revising the manuscript.","order":8,"name":"Ethics","label":"Authors\u2019 Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}